TGF-β is known as a CSC marker and modulator [47,48], so an increase in the levels of TGF-β is expected to play a major role in acquiring and maintaining cancer stem-like properties in Hep3B/ρ0 cells. The gene discussed is TGFB1; the disease is cancer.